Zobrazeno 1 - 10
of 352
pro vyhledávání: '"J, van den Akker"'
Autor:
E. Stouthamer, G. Erkens, K. Cohen, D. Hegger, P. Driessen, H. P. Weikard, M. Hefting, R. Hanssen, P. Fokker, J. van den Akker, F. Groothuijse, M. van Rijswick
Publikováno v:
Proceedings of the International Association of Hydrological Sciences, Vol 382, Pp 815-819 (2020)
In the Netherlands land subsidence is a continuously ongoing process. Consequently, an increasing number of people and economic assets are exposed to subsidence, damage costs are soaring, and flood risk and greenhouse gas emissions are increasing. In
Externí odkaz:
https://doaj.org/article/1c71c9e1985347688d4a8706b0de4705
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Eline Huizing, Cornelis G. Vos, Robin G. Hulsebos, Peter J. van den Akker, Gert Jan de Borst, Çağdaş Ünlü
Publikováno v:
The Surgery Journal, Vol 04, Iss 02, Pp e96-e101 (2018)
Abstract Objectives Guidelines recommend routine patching to prevent restenosis following carotid endarterectomy, mainly based on studies performed many years ago with different perioperative care and medical treatment compared with current standar
Externí odkaz:
https://doaj.org/article/cd42560d962440f28ba77becc6f65b0f
Publikováno v:
Haematologica, Vol 92, Iss 1 (2007)
The number of CML patients in child-bearing age and treated with imatinib is increasing. These women may want to be pregnant or are actually pregnant while on imatinib. Physicians do not know when to stop the treatment and what the risks are for the
Externí odkaz:
https://doaj.org/article/ba011751ccf64337a9e016850ad49d0f
Autor:
Taylor Sittler, O Leitner, E Gil, SB Adams, Lauren Ryan, Beth Crawford, L.J. van 't Veer, J. van den Akker, Salina Chan
Publikováno v:
Cancer Research. 77:P3-08
Background Among women with an elevated risk of hereditary breast and ovarian cancer who previously tested negative for pathogenic mutations in BRCA1 and BRCA2, a subset remain at increased risk of having hereditary breast, ovarian or other cancers,
Autor:
Payal D. Shah, A. R. Bradbury, J. van den Akker, E Gil, Simon, Kara N. Maxwell, S Kim, Susan M. Domchek, Laura DiGiovanni, K. L. Nathanson
Publikováno v:
Cancer Research. 77:P5-10
Background: Few reports describe the spectrum of mutations in breast and ovarian cancer predisposition genes found specifically in African Americans. Methods: 560 women who self-identified as African American (AA) from the University of Pennsylvania
Publikováno v:
Cancer Research. 78:P4-06
Objectives: Here, we describe the characteristics of 3,011 individuals with a self-reported diagnosis of breast cancer who received a multi-gene panel genetic test for hereditary cancer risk. Methods: These 3,011 patients were referred physician orde
Autor:
Peter J. van den Akker, Gert J. de Borst, Michiel A. Schreve, Çağdaş Ünlü, Cornelis G. Vos, Eline Huizing
Publikováno v:
Journal of vascular surgery. 69(6)
Background Guidelines recommend routine patching after carotid endarterectomy (CEA) on the basis of a lower restenosis rate and presumed lower procedural stroke rate than with primary repair. Underlying evidence is based on studies performed decades
Autor:
Çağdaş Ünlü, Gert J. de Borst, Peter J. van den Akker, Cornelis G. Vos, Robin G. Hulsebos, Eline Huizing
Publikováno v:
The Surgery Journal, Vol 04, Iss 02, Pp e96-e101 (2018)
Objectives Guidelines recommend routine patching to prevent restenosis following carotid endarterectomy, mainly based on studies performed many years ago with different perioperative care and medical treatment compared with current standards. Aim of
Autor:
Patrizia Dell'Orto, J. van den Akker, Giuseppe Viale, E.J.T. Rutgers, Lisette Stork-Sloots, Jan Bogaerts, L.J. van 't Veer, F de Snoo, Martine Piccart-Gebhart, Leen Slaets, Leila Russo, Fatima Cardoso, Annuska M. Glas
Publikováno v:
Annals of Oncology. 25:816-823
To investigate the correlation of TargetPrint with local and central immunohistochemistry/fluorescence in situ hybridization assessment of estrogen (ER), progesterone (PgR), and human epidermal growth factor receptor 2 (HER2) in the first 800 patient